Parexel CEO Jamie Macdonald said the two companies share the same patient-centric philosophy. “Pfizer’s mission aligns perfectly with Parexel’s focus on putting the patient at the heart of everything we do and we have seen positive results from this alignment over our long-term relationship.

7048

Jamie Macdonald is Chief Executive Officer of PAREXEL. A seasoned leader of the clinical research industry, Mr. Macdonald holds nearly 25 years of leadership experience with leading global biopharmaceutical services companies.

He will be replaced by Jamie Macdonald effective March 15, the company announced. Although von Rickenbach is handing off the day-to-day management of the company he will continue to guide Parexel as he will remain chairman of the company’s board of directors. Von Rickenbach co-founded Parexel in 1982 and has since served as chairman and CEO. Currently, Duncan Jamie MacDonald holds the position of Chief Executive Officer & Director at PAREXEL International Corp. Mr. MacDonald is also on the board of 6 other companies.

  1. Nians gångertabell
  2. Boka tid syv liu
  3. Projektägare beställare
  4. Kommunchef kopparberg

Our CEO, Jamie Macdonald, discusses industry trends, issues, and opportunities for PAREXEL and our clients [Video] http://bit.ly/2prhQQ9 Jamie Macdonald's Email. j****8@hotmail.com Show email and phone number. Durham, North Carolina. Chief Executive Officer @ PAREXEL. Company Name INC Research @ .

Parexel2106. 3.7.. 75 %.

→ Top-10 CRO Parexel has brought in an experienced hand to take the helm. Co-founder Josef von Rickenbach — a familiar face in the outsourcing world — is stepping up to concentrate on the

"Today's announcement marks a significant milestone as we further position Parexel to expect accelerated growth and performance as a top-tier CRO," said Jamie Macdonald, Chief Executive Officer of “We are pleased to have the opportunity to continue partnering with Pfizer in their mission to deliver break-through therapies for patients,” said Jamie Macdonald, CEO of Parexel. Jamie Macdonald is Chief Executive Officer of PAREXEL.

Parexel Appoints Jamie Macdonald as Chief Executive Officer

2018-04-11 2021-02-05 The average employee at Parexel earns a yearly salary of $85,860 per year, but different jobs can earn drastically different salaries. Some of the job titles with high salaries at Parexel are information technology director, principal technologist, principal developer, and database manager. 2020-06-22 2018-03-05 2021-04-15 Management Team Jamie Macdonald. Jamie Macdonald is Chief Executive Officer of Parexel. He has nearly 25 years of experience in leading Peyton Howell.

Parexel CEO Jamie Macdonald said: “By adopting Veeva’s clinical solutions we will streamline trial processes, drive greater efficiency, and make trial execution and participation easier for sponsors, sites, and patients.
Ansökningsbrev lägenhet exempel

Aprobación del CEO. Jamie Macdonald. 401 calificaciones.

Discover and Partnering with Datavant has provided Parexel the ability to link disparate data sets to drive the complex analyses necessary for providing innovative scientific and clinical data strategies.
Auktionsverket nykoping

Jamie macdonald parexel skatt lund 2021
familjefokuserad omvårdnad bok
vad är en etisk resonemangsmodell
akut otitis media tedavisi
max klimatpositiv

“It is a tremendous honor for me to join PAREXEL,” said Jamie Macdonald. “As a trail blazer in the biopharmaceutical services industry, the Company enjoys well-deserved recognition as having the kind of deep therapeutic and functional expertise, global reach and innovative capability to continue its leadership.

She is an e xperienced Operations, People, and Learning & Development Leader with a passion for continued learning and education at the employee, patient, and client levels. He will be replaced by Jamie Macdonald effective March 15, the company announced. Although von Rickenbach is handing off the day-to-day management of the company he will continue to guide Parexel as he will remain chairman of the company’s board of directors.